Optimization of Intravenous Odronextamab Step-up Regimen for Reducing the Risk of High-Grade Cytokine Release Syndrome

MLA

Min Zhu, et al. “Optimization of Intravenous Odronextamab Step-up Regimen for Reducing the Risk of High-Grade Cytokine Release Syndrome.” Blood, vol. 140, Nov. 2022, pp. 11560–61. EBSCOhost, https://doi.org/10.1182/blood-2022-158415.

APA

Min Zhu, Jurriaan Brouwer-Visser, Srikanth R. Ambati, Hesham Mohamed, Vladimir Jankovic, Fang Wang, Hong Yan, Jingxian Cai, Carolina Leite De Oliveira, Melanie Ufkin, John D. Davis, Aafia Chaudhry, & Masood Khaksar Toroghi. (2022). Optimization of Intravenous Odronextamab Step-up Regimen for Reducing the Risk of High-Grade Cytokine Release Syndrome. Blood, 140, 11560–11561. https://doi.org/10.1182/blood-2022-158415

Chicago

Min Zhu, Jurriaan Brouwer-Visser, Srikanth R. Ambati, Hesham Mohamed, Vladimir Jankovic, Fang Wang, Hong Yan, et al. 2022. “Optimization of Intravenous Odronextamab Step-up Regimen for Reducing the Risk of High-Grade Cytokine Release Syndrome.” Blood 140 (November): 11560–61. doi:10.1182/blood-2022-158415.